Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
46.46
0.39 (0.85%)
At close: Aug 15, 2025, 3:59 PM
46.91
0.96%
After-hours: Aug 15, 2025, 07:34 PM EDT
Avidity Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 3.85M | 1.57M | 2.97M | 2.34M | 2.04M | 3.54M | 2.19M | 2.82M | 2.32M | 2.23M | 2.77M | 2.48M | 2.18M | 1.79M | 1.85M | 2.16M | 2.61M | 2.7M |
Cost of Revenue | 814K | n/a | n/a | 710K | 687K | 641K | 615K | -854K | 1.26M | 1.08M | 381K | 400K | 39.79M | 314K | 208K | 24.83M | 22.71M | 20.68M |
Gross Profit | 3.03M | 1.57M | 2.97M | 2.34M | 1.36M | 2.9M | 1.58M | 3.67M | 1.05M | 1.15M | 2.39M | 2.08M | -37.61M | 1.48M | 1.64M | -22.67M | -20.1M | -17.97M |
Operating Income | -171.14M | -131.52M | -120.99M | -98.13M | -82.63M | -77.19M | -66.74M | -58.63M | -52.63M | -52.78M | -53.23M | -44.93M | -46.3M | -34.46M | -38.55M | -29.28M | -26.37M | -23.86M |
Interest Income | 14.48M | 16.18M | 18.53M | 17.97M | 11.95M | 8.43M | 6.41M | 6.28M | 5.77M | 5.52M | 2.77M | 1.34M | 611K | 250K | 55K | 17K | 16K | 16K |
Pretax Income | -157.31M | -115.77M | -102.26M | -80.4M | -70.79M | -68.86M | -60.44M | -52.36M | -47.02M | -52.39M | -50.47M | -43.6M | -45.69M | -34.23M | -38.54M | -29.27M | -26.35M | -23.84M |
Net Income | -157.31M | -115.77M | -102.26M | -80.4M | -70.79M | -68.86M | -60.44M | -52.36M | -47.02M | -47.19M | -47.72M | -42.27M | -45.69M | -34.01M | -38.53M | -29.27M | -26.35M | -23.84M |
Selling & General & Admin | 36.86M | 33.6M | 28.34M | 23.27M | 20.73M | 13.26M | 15.5M | 13.73M | 12.28M | 12.06M | 10.38M | 10.09M | 8.69M | 8.57M | 7.43M | 6.61M | 6.27M | 5.88M |
Research & Development | 138.13M | 99.49M | 95.63M | 77.2M | 63.94M | 66.83M | 52.82M | 47.71M | 42.67M | 47.77M | 45.61M | 37.32M | 39.79M | 27.69M | 32.97M | 24.83M | 22.71M | 20.68M |
Other Expenses | n/a | n/a | n/a | n/a | -687K | n/a | n/a | -1.3M | -162K | 5.2M | n/a | -12K | -2K | -25K | 9K | -11K | -2K | -3K |
Operating Expenses | 174.99M | 133.09M | 123.96M | 100.47M | 83.98M | 80.09M | 68.32M | 60.14M | 54.95M | 59.83M | 55.99M | 47.41M | 48.48M | 36.26M | 40.4M | 31.44M | 28.97M | 26.56M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -641K | -615K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 174.99M | 133.09M | 123.96M | 100.47M | 84.67M | 80.73M | 68.94M | 61.44M | 54.95M | 59.83M | 55.99M | 47.41M | 48.48M | 36.26M | 40.4M | 31.44M | 28.97M | 26.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -5.2M | -2.75M | -1.33M | n/a | -225K | -9K | -6K | -14K | -13K |
Shares Outstanding (Basic) | 129.62M | 129.23M | 128.5M | 123.38M | 106.93M | 87.21M | 76.05M | 74.1M | 71.39M | 70.43M | 57.3M | 53.07M | 49.93M | 48.22M | 23.61M | 43.05M | 37.58M | 37.52M |
Shares Outstanding (Diluted) | 129.62M | 129.23M | 128.5M | 123.38M | 106.93M | 87.21M | 76.05M | 74.1M | 71.39M | 70.43M | 57.3M | 53.07M | 49.93M | 48.25M | 23.61M | 43.27M | 37.58M | 37.52M |
EPS (Basic) | -1.21 | -0.9 | -0.8 | -0.65 | -0.66 | -0.79 | -0.79 | -0.71 | -0.66 | -0.67 | -0.83 | -0.8 | -0.92 | -0.71 | -1.63 | -0.68 | -0.7 | -0.64 |
EPS (Diluted) | -1.21 | -0.9 | -0.8 | -0.65 | -0.66 | -0.79 | -0.79 | -0.71 | -0.66 | -0.67 | -0.83 | -0.8 | -0.92 | -0.7 | -1.63 | -0.68 | -0.7 | -0.64 |
EBITDA | -171.14M | -130.73M | -120.25M | -97.42M | -81.94M | -76.55M | -66.13M | -58.06M | -52.1M | -57.2M | -50.09M | -44.56M | -45.98M | -34.15M | -38.33M | -29.1M | -26.22M | -23.75M |
EBIT | -157.31M | -131.52M | -120.99M | -98.13M | -82.63M | -77.19M | -66.74M | -58.63M | -52.63M | -57.6M | -50.47M | -44.93M | -46.3M | -34.46M | -38.54M | -29.28M | -26.37M | -23.86M |
Depreciation & Amortization | 814K | 785K | 738K | 710K | 687K | 641K | 615K | 566K | 1.26M | 1.08M | 381K | 400K | 300K | 314K | 208K | 200K | 147K | 108K |